Astellas Pharma Inc - Company Profile
Powered by
All the data and insights you need on Astellas Pharma Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Astellas Pharma Inc Strategy Report
- Understand Astellas Pharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Astellas Pharma Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
WO2022192622A1 | Application | COMPOSITIONS AND METHODS FOR TREATING X-LINKED MYOTUBULAR MYOPATHY | September 15, 2022 | |
EP3906088A4 | Search Report | LEISTUNGSSTEUERUNGEN FÜR EINE MIT ULTRASCHALLWELLEN ANGETRIEBENE IMPLANTIERBARE VORRICHTUNG | A61B2560/0219; A61B5/002; A61B5/0028; A61B5/0031; A61B5/01; A61B5/021; A61B5/024; A61B5/14532; A61B5/14539; A61B5/14556; A61B5/24; A61B5/4035; A61B5/4047; A61B5/4052; A61B5/686; A61N1/08; A61N1/36053; A61N1/36128; A61N1/37211; A61N1/37276; A61N1/3787; H02J50/15; H02J50/80; H02J7/0049; H02J7/00711 | September 14, 2022 |
CN110167926B | Grant | 聚-ADP核糖聚合酶(PARP)抑制剂 | A61K31/517; A61K31/519; A61P13/12; A61P21/00; A61P25/00; A61P3/00; A61P35/00; A61P9/00; C07D239/74; C07D401/06; C07D401/08; C07D401/14; C07D403/06; C07D403/08; C07D403/14; C07D405/10; C07D405/14; C07D417/08; C07D417/14; C07D471/04; C07D487/04; C07D495/04 | September 13, 2022 |
AU2022218516A1 | Application | Improved assays for potency of human retinal pigment epithelium (RPE) cells and photoreceptor progenitors | G01N15/14; G01N21/6486; G01N2800/164; G01N33/5005; G01N33/582; G01N33/84 | September 08, 2022 |
US20220280572A1 | Application | METHODS OF TREATING VASCULAR DISEASES | A61K35/28; A61K35/44; A61P9/12; C12N5/0647; C12N5/069 | September 08, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward